Source: Pharmaceutics. Unidade: IFSC
Subjects: DOENÇA DE CHAGAS, PLANEJAMENTO DE FÁRMACOS
ABNT
MEIER, Lidiane et al. In silico studies and biological evaluation of thiosemicarbazones as cruzain-targeting trypanocidal agents for Chagas disease. Pharmaceutics, v. 18, n. Ja 2026, p. 65-1-65-14, 2026Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics18010065. Acesso em: 25 jan. 2026.APA
Meier, L., Melo Milena F. C. V. de,, Abreu, H. R., Oliveira, I. M. de, Sens, L., Döring, T. H., et al. (2026). In silico studies and biological evaluation of thiosemicarbazones as cruzain-targeting trypanocidal agents for Chagas disease. Pharmaceutics, 18( Ja 2026), 65-1-65-14. doi:10.3390/pharmaceutics18010065NLM
Meier L, Melo Milena F. C. V. de, Abreu HR, Oliveira IM de, Sens L, Döring TH, Krogh R, Beatriz A, Andricopulo AD, Saba S, Oliveira AS de, Rafique J. In silico studies and biological evaluation of thiosemicarbazones as cruzain-targeting trypanocidal agents for Chagas disease [Internet]. Pharmaceutics. 2026 ; 18( Ja 2026): 65-1-65-14.[citado 2026 jan. 25 ] Available from: https://doi.org/10.3390/pharmaceutics18010065Vancouver
Meier L, Melo Milena F. C. V. de, Abreu HR, Oliveira IM de, Sens L, Döring TH, Krogh R, Beatriz A, Andricopulo AD, Saba S, Oliveira AS de, Rafique J. In silico studies and biological evaluation of thiosemicarbazones as cruzain-targeting trypanocidal agents for Chagas disease [Internet]. Pharmaceutics. 2026 ; 18( Ja 2026): 65-1-65-14.[citado 2026 jan. 25 ] Available from: https://doi.org/10.3390/pharmaceutics18010065
